Newsroom

Updated versions of the draft topics for IHI calls 6 and 7 are available now on the Future Opportunities page. We hope to launch the calls early next year.

If you have an idea for IHI’s future research, we’d love to hear from you! Discover our Ideas Incubator and inspire health innovation at IHI.

The draft texts of the topics slated for inclusion in IHI’s next calls for proposals are now available online.

CLAIMS will develop an AI-based platform for multiple sclerosis patients that would help to predict the course of the disease and identify the best treatments for them.

Following surgery to remove a tumour, blood tests could help to identify which patients really need further treatment, and which don’t.

IMAGIO focuses on ‘interventional oncology’, which uses miniaturised instruments to target cancer cells more precisely, thereby sparing health cells.

The topics contribute to key EU policies such as the European Green Deal and the '3Rs' goals of replacing, reducing and refining the use of animals in research.

The project aims to set up a digital platform to improve the diagnosis and personalised treatment of people with Alzheimer’s plus other diseases.

The topics cover subjects as diverse as cutting animal testing in research, sustainability in healthcare, rare diseases, and equitable access to clinical research.

The 120 members of the pool include both patients and caregivers and have experience of a wide range of health issues.

IDERHA will create an open health data platform that will facilitate the integration and analysis of diverse types of data, and use it to transform lung cancer diagnosis and care.

Dr Blomberg has worked in both research and leadership roles in Europe's life sciences sector, and is currently Director of ELIXIR, the life sciences data infrastructure.

Addressing cancer and neurodegenerative diseases, and bringing on board sectors as diverse as pharmaceuticals, medical technology, big data and imaging, the projects exemplify IHI...

The topics cover subjects as diverse as sustainability in healthcare, rare diseases, and equitable access to clinical research. Registration for the IHI Call Days is also open.

IHI is calling on patients and informal caregivers to apply to be part of a new IHI Patient Pool which will strengthen IHI’s ties with the patient community, and make it easier to...

The two organisations have signed a Memorandum of Understanding that will facilitate collaboration and allow them to leverage their strengths, networks and expertise.

The Innovative Health Initiative (IHI) has launched its third call for proposals, featuring topics covering rare diseases and mental health, and addressing challenges such as...

As we mark the Innovative Health Initiative’s first birthday on 30 November, we look back on what we have achieved so far, and offer a glimpse of our plans for the coming year.

Updated versions of the draft topics for IHI calls 3 and 4 have been published on the Future Opportunities page.

The Science Innovation Panel (SIP) is a new body set up under IHI to advise the Governing Board on a range of matters. In an interview with the IHI Programme Office, chair Anna...

The short brochure describes recent IMI project results in fields such as cancer, antimicrobial resistance, COVID-19 and more.

Digital technologies in mental health care, advanced therapies for rare diseases, and improving hospital care are among the topics pencilled in for IHI’s next calls for proposals.

Dr Hugh Laverty has taken over as interim Executive Director at the Innovative Health Initiative (IHI), following the departure of Dr Pierre Meulien.

As Pierre Meulien completes his 7-year term as Executive Director of IHI, he reflects on how the research and innovation process has changed and will continue to undergo rapid...

Through the States Representatives Group (SRG), Member States provide vital input into the direction of IHI, as SRG chair Martha Cahill explains in this interview.

The joint undertakings are about creating public-private partnerships (PPPs) – and IHI is no exception. In an interview, the European Commission’s Irene Norstedt, chair of the...

The Innovative Health Initiative (IHI) has launched its first calls for proposals, with topics on diseases such as cancer, cardiovascular disease and neurodegenerative diseases, as...

Cancer, heart disease and neurodegenerative diseases as well as health data and early feasibility studies are the focus of IHI’s first calls for proposals, which are due to be...

The newly appointed members of the Innovative Health Initiative Science and Innovation Panel have a wealth of scientific expertise and extensive experience of diverse aspects of...

IHI seeks an ‘outstanding and dynamic professional’ with top leadership, scientific and people skills to take on the role of Executive Director of the public-private partnership...

The IHI Governing Board has formally approved the Strategic Research and Innovation Agenda (SRIA), which will guide IHI’s scientific priorities in the years to come.

The Innovative Health Initiative (IHI) is looking for people who want to represent the scientific and wider healthcare communities in its new Science and Innovation Panel (SIP)...

Cancer, heart disease and neurodegenerative diseases are among the themes that could be included in the first calls for proposals launched under the new Innovative Health...

The eight members of the Governing Board represent the Innovative Health Initiative (IHI) public and private partners. The chair of the newly-created board is Irene Norstedt of the...

We welcome entry into force of the legislation creating the Innovative Health Initiative (IHI), a new European partnership for health under Horizon Europe.

The Innovative Medicines Initiative (IMI) organically grew into a powerhouse of international alliances. The new partnership’s multi-sectoral nature means that the catchment will...